These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1848974)

  • 1. Effect of amiodarone on the phospholipid and lamellar body content of lymphoblasts in vitro and peripheral blood lymphocytes in vivo.
    Hostetler KY; Vande Berg J; Aldern KA; Brophy GT
    Biochem Pharmacol; 1991 Mar 15-Apr 1; 41(6-7):1007-13. PubMed ID: 1848974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone-induced phospholipidosis in rat alveolar macrophages.
    Reasor MJ; Ogle CL; Walker ER; Kacew S
    Am Rev Respir Dis; 1988 Mar; 137(3):510-8. PubMed ID: 2830811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone- and desethylamiodarone-induced myelinoid inclusion bodies and toxicity in cultured rat hepatocytes.
    Somani P; Bandyopadhyay S; Klaunig JE; Gross SA
    Hepatology; 1990 Jan; 11(1):81-92. PubMed ID: 2153095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral neutrophil inclusions in amiodarone treated patients.
    Adams PC; Sloan P; Morley AR; Holt DW
    Br J Clin Pharmacol; 1986 Dec; 22(6):736-8. PubMed ID: 3032227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic amiodarone treatment on cat myocardial phospholipid content and on in vitro phospholipid catabolism.
    Shaikh NA; Downar E
    Mol Cell Biochem; 1987 Nov; 78(1):17-25. PubMed ID: 3454865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular changes of rat myocardium after treatment with amiodarone or desethylamiodarone, studied with electron microscopy.
    Snyder VL; Bandyopadhyay S; Collins J; Gross SA; Somani P; Didio LJ
    J Submicrosc Cytol Pathol; 1990 Jan; 22(1):71-8. PubMed ID: 2155704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of lamellar body quantification in leukocytes in amiodarone toxicity].
    Vargas FS; Falzoni R; Terra Filho M; Cukier A; Carvalho-Pinto RM; Pileggi F
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):184-9. PubMed ID: 1668861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone and desethylamiodarone tissue uptake in rats chronically treated with amiodarone is non-linear with the dose.
    Latini R; Bizzi A; Cini M; Veneroni E; Marchi S; Riva E
    J Pharm Pharmacol; 1987 Jun; 39(6):426-31. PubMed ID: 2886599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone--an inhibitor of phospholipase activity: a comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine.
    Shaikh NA; Downar E; Butany J
    Mol Cell Biochem; 1987 Aug; 76(2):163-72. PubMed ID: 2823097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone and desethylamiodarone toxicity in isolated hepatocytes in culture.
    Gross SA; Bandyopadhyay S; Klaunig JE; Somani P
    Proc Soc Exp Biol Med; 1989 Feb; 190(2):163-9. PubMed ID: 2536944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-ray microanalysis of cultured alveolar macrophages with phospholipidosis.
    Lee P; Kirk RG; Reasor MJ
    Exp Mol Pathol; 1993 Apr; 58(2):96-104. PubMed ID: 8388333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone pulmonary toxicity.
    Colgan T; Simon GT; Kay JM; Pugsley SO; Eydt J
    Ultrastruct Pathol; 1984; 6(2-3):199-207. PubMed ID: 6087525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of amiodarone on phospholipid content and composition in heart, lung, kidney and skeletal muscle: relationship to alteration of thyroid function.
    Rabkin SW
    Pharmacology; 2006; 76(3):129-35. PubMed ID: 16401913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone toxicity. II. Desethylamiodarone-induced phospholipidosis and ultrastructural changes during repeated administration in rats.
    Kannan R; Sarma JS; Guha M; Venkataraman K
    Fundam Appl Toxicol; 1991 Jan; 16(1):103-9. PubMed ID: 2019335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylacetylglycine, a putative biomarker of phospholipidosis: its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model.
    Delaney J; Neville WA; Swain A; Miles A; Leonard MS; Waterfield CJ
    Biomarkers; 2004; 9(3):271-90. PubMed ID: 15764292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes, and blood leukocytes of patients with amiodarone pulmonary toxicity.
    Dake MD; Madison JM; Montgomery CK; Shellito JE; Hinchcliffe WA; Winkler ML; Bainton DF
    Am J Med; 1985 Mar; 78(3):506-12. PubMed ID: 2983550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of phospholipase A inhibition in amiodarone pulmonary toxicity in rats.
    Hostetler KY; Reasor MJ; Walker ER; Yazaki PJ; Frazee BW
    Biochim Biophys Acta; 1986 Feb; 875(2):400-5. PubMed ID: 3942773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of amiodarone therapy on the time course of myocardial phospholipid hydrolysis during in vitro total ischaemia in cat hearts.
    Shaikh NA
    J Mol Cell Cardiol; 1992 May; 24(5):507-21. PubMed ID: 1635074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of alveolar macrophages to amiodarone and desethylamiodarone, in vitro.
    Ogle CL; Reasor MJ
    Toxicology; 1990 May; 62(2):227-38. PubMed ID: 2162090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
    Somani P; Simon VA; McManus K
    Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.